How Will AC Immune’s Phase II Fail Impact Alzheimer’s Research?
AC Immune and Genentech’s drug has failed to slow the progression of Alzheimer’s disease in…
29/09/2020 - 6 minutes
AC Immune and Genentech’s drug has failed to slow the progression of Alzheimer’s disease in…
An epigenetics drug developed by the Spanish biopharmaceutical company Oryzon has reduced aggressive behavior in…
AXON Neuroscience has presented positive clinical results for its Alzheimer's vaccine and announced a new…
Biotech is one of the main forces driving the development of effective therapies to treat neurological and…
Axon Neuroscience is starting a Phase II trial with its immunotherapy for Alzheimer's disease, which…
Eastern Europe is home to fascinating culture and rising economies, but how is the Biotech…